Clinical Trial: Two-Dose Methotrexate for Ectopic Pregnancy
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Two-Dose Methotrexate for Ectopic Pregnancy
Brief Summary: This study examines the safety and acceptability of a novel "two dose" regimen of methotrexate to treat ectopic pregnancy.
Detailed Summary: The regimen is an attempt to create a middle ground between the 2 commonly used regimens - "single dose" and "multi dose". The "multi dose" regimen is more effective, but the "single dose" regimen is more convenient for patients and has fewer side effects.
Sponsor: University of Pennsylvania
Current Primary Outcome: Prevalence of side effects [ Time Frame: Till quantitative bhCG values fall to zero or below 5mIU/mL ]
Original Primary Outcome: Prevalence of side effects
Current Secondary Outcome: Efficacy of treatment of ectopic pregnancy (defined as no surgical intervention) [ Time Frame: Till quantitative bhCG values fall to zero or below 5mIU/mL ]
Original Secondary Outcome: Efficacy of treatment of ectopic pregnancy (defined as no surgical intervention)
Information By: University of Pennsylvania
Dates:
Date Received: September 13, 2005
Date Started: March 2001
Date Completion:
Last Updated: August 8, 2011
Last Verified: August 2011